Evidence map›Paper›PMID 31863356›Full record

ArticleVirologica Sinica2020

Screening and Identification of Marburg Virus Entry Inhibitors Using Approved Drugs.

Li Zhang, Shan Lei, Hui Xie, Qianqian Li, Shuo Liu, Qiang Liu, Weijin Huang, Xinyue Xiao, Youchun Wang

Open access · greenAbstract readLetterComment
In one paragraph

Article in Virologica Sinica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Pseudotyped Viruses for Marburgvirus and Ebolavirus.Advances in experimental medicine and biology · 2023
    Article
  3. Review
  4. Article
  5. Medicinal Fungi with Antiviral Effect.Molecules (Basel, Switzerland) · 2022
    Review
  6. Ebola Virus Entry Inhibitors.Advances in experimental medicine and biology · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Li ZhangDivision of HIV/AIDS and Sexually-transmitted Virus Vaccines, National Institutes for Food and Drug Control, Beijing, 102629, China.
Shan LeiDivision of HIV/AIDS and Sexually-transmitted Virus Vaccines, National Institutes for Food and Drug Control, Beijing, 102629, China.
Hui XieDivision of HIV/AIDS and Sexually-transmitted Virus Vaccines, National Institutes for Food and Drug Control, Beijing, 102629, China.
Qianqian LiDivision of HIV/AIDS and Sexually-transmitted Virus Vaccines, National Institutes for Food and Drug Control, Beijing, 102629, China.
Shuo LiuDivision of HIV/AIDS and Sexually-transmitted Virus Vaccines, National Institutes for Food and Drug Control, Beijing, 102629, China.
Qiang LiuDivision of HIV/AIDS and Sexually-transmitted Virus Vaccines, National Institutes for Food and Drug Control, Beijing, 102629, China.
Weijin HuangDivision of HIV/AIDS and Sexually-transmitted Virus Vaccines, National Institutes for Food and Drug Control, Beijing, 102629, China.
Xinyue XiaoInstitute for Reference Standards and Standardization, National Institutes for Food and Drug Control, Beijing, 102629, China.
Youchun WangDivision of HIV/AIDS and Sexually-transmitted Virus Vaccines, National Institutes for Food and Drug Control, Beijing, 102629, China. wangyc@nifdc.org.cn.ORCID 0000-0001-9769-5141
National Institutes for Food and Drug Control · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

EbolavirusMarburgvirusVirusesAnimalsMiceVirus Internalization

Identifiers

PMID31863356
PMCPMC7198659
OpenAlexW2995912174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.